Knowledge Leaders Capital’s Novo Nordisk NVO Stock Holding History

Knowledge Leaders Capital’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-5,478	Closed	-$304K	–	130
2022 Q1	$304K	Buy	5,478 +1,332	+32%	+$68.4K	0.22%	110
2021 Q4	$232K	Buy	+4,146	New	+$225K	0.17%	116
2019 Q1	–	Sell	-24,298	Closed	-$560K	–	39
2018 Q4	$560K	Buy	+24,298	New	+$540K	0.76%	36

Other funds holding NVO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Knowledge Leaders Capital's NVO Position: Q2 2022 in Review

Knowledge Leaders Capital sold out of Novo Nordisk (NVO) in Q2 2022, closing a stake of 5,478 shares — an estimated $304K sold.

Knowledge Leaders Capital first reported a position in NVO in Q4 2018 and held it in 3 quarters. The position peaked at $560K in Q4 2018. 933 funds tracked by Wall St. Rank hold NVO as of Q2 2022.

Knowledge Leaders Capital reported no remaining Novo Nordisk position as of Q2 2022 after selling out during the quarter.
Knowledge Leaders Capital sold 5,478 Novo Nordisk shares in Q2 2022, an estimated $304K.
Knowledge Leaders Capital first reported a position in Novo Nordisk in Q4 2018 and held it in 3 quarters.
Knowledge Leaders Capital's Novo Nordisk position peaked at $560K in Q4 2018.
933 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2022.

Based on Knowledge Leaders Capital's 13F filing for Q2 2022, filed 3 Aug 2022.